India News | DRDO, AIIMS-Rishikesh Ink MoU for Clinical Trials in Field of Biomedical Devices

Get latest articles and stories on India at LatestLY. An institute of the DRDO has signed an agreement with AIIMS, Rishikesh for conducting "clinical trials" and advanced research in the field of biomedical devices related to human performance in extreme environments.

New Delhi, Jul 5 (PTI) An institute of the DRDO has signed an agreement with AIIMS, Rishikesh for conducting "clinical trials" and advanced research in the field of biomedical devices related to human performance in extreme environments.

The collaboration between the Defence Research and Development Organisation (DRDO) and the All India Institute of Medical Sciences (AIIMS) will facilitate the development of products, technologies and strategies for the "mitigation of effects" of extreme environments on human performance, officials said.

Also Read | Uttar Pradesh: 6 Policemen Suspended for Circulating Objectionable Post on Social Media on Ex CM Akhilesh Yadav.

Defence Institute of Physiology and Allied Sciences (DIPAS) of the DRDO has signed an MoU with AIIMS, Rishikesh for "conducting clinical trials and advanced research in the field of biomedical devices and supplements related to human performance in extreme environments," a senior official said.

This collaborative effort will facilitate the formulation and development of products, technologies and strategies for mitigation of effects of extreme environment on human performance, they said.

Also Read | 'Squinted Version': Rahul Gandhi's Lawyer on ED Allegations in National Herald Case.

The DRDO also shared some photos of the Memorandum of Understanding (MoU) signing in a post on X late Friday.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now